Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
2.460
-0.100 (-3.91%)
At close: Dec 5, 2025, 4:00 PM EST
2.480
+0.020 (0.81%)
After-hours: Dec 5, 2025, 5:17 PM EST
Definitive Healthcare Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Definitive Healthcare stock have an average target of 4.28, with a low estimate of 3.00 and a high estimate of 6.00. The average target predicts an increase of 73.98% from the current stock price of 2.46.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Definitive Healthcare stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 4 | 4 | 4 | 4 | 4 |
| Sell | 2 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +62.60% | Nov 10, 2025 |
| Stifel | Stifel | Strong Buy Maintains $5 → $6 | Strong Buy | Maintains | $5 → $6 | +143.90% | Aug 8, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $3 → $3.4 | Hold | Maintains | $3 → $3.4 | +38.21% | May 12, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $4.5 → $3 | Hold | Maintains | $4.5 → $3 | +21.95% | Mar 4, 2025 |
| Barclays | Barclays | Sell Maintains $4 → $3 | Sell | Maintains | $4 → $3 | +21.95% | Mar 3, 2025 |
Financial Forecast
Revenue This Year
246.52M
from 252.20M
Decreased by -2.25%
Revenue Next Year
241.67M
from 246.52M
Decreased by -1.97%
EPS This Year
0.24
from -3.54
EPS Next Year
0.27
from 0.24
Increased by 13.22%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 251.8M | 253.7M | |
| Avg | 246.5M | 241.7M | |
| Low | 232.3M | 225.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.2% | 2.9% | |
| Avg | -2.3% | -2.0% | |
| Low | -7.9% | -8.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.25 | 0.36 | |
| Avg | 0.24 | 0.27 | |
| Low | 0.21 | 0.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 47.4% | |
| Avg | - | 13.2% | |
| Low | - | -19.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.